South Egypt Cancer instIitute
Asyut, 171516, Egypt
NCT Number: NCT03164590
This study aims to compare the effects of local wound infiltration with ketamine versus dexmedetomidine when added to bupivacaine on inflammatory cytokine response after total abdominal hysterectomy.
Looking for future studies?
Notify Me18 year–60 year
Female
Interventional
Phase 4
Asyut, 171516, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients receive local anesthetic wound infiltration with 1 mg /kg ketamine
patients receive local anesthetic wound infiltration with 1µg/kg dexmedetomidine
patients receive local anesthetic wound infiltration with bupivacaine 0.5 % diluted in 20 ml saline
Time frame: 24 hours
severity of pain at rest and on coughing will be assessed using a 10-cm Visual Analog Scale (0 = no pain and 10 = worst imaginable pain)
Time frame: 24 hours
sedation by using sedation score
Assiut University
Other
Effects of Local Wound Infiltration With Ketamine Versus Dexmedetomidine Added to Bupivacaine on Inflammatory Cytokines Response After Total Abdominal Hysterectomy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03586661
Adnexal Diseases, Deleterious BRCA1 Gene Mutation
Houston, Texas, United States
View Trial DetailsNCT03460483
Colonic Diseases, Colorectal Neoplasms
Akron, Ohio, United States
View Trial DetailsNCT07074067
Endometrial Adenocarcinoma
Murcia, Spain
View Trial DetailsNCT04972682
Endometrial Adenocarcinoma, Endometrial Cancer
Istra, Moscow Oblast, Russia
View Trial Details